Intestinal Permeability in Inflammatory Bowel Disease: Pathogenesis, Clinical Evaluation, and Therapy of Leaky Gut
Open accessThe DOI matches its Crossref record; 146 of the 146 references it cites were found in a registry or an index.
Abstract
The pathogenesis of inflammatory bowel disease (IBD) is multifactorial with data suggesting the role of a disturbed interaction between the gut and the intestinal microbiota. A defective mucosal barrier may result in increased intestinal permeability which promotes the exposition to luminal content and triggers an immunological response that promotes intestinal inflammation. IBD patients display several defects in the many specialized components of mucosal barrier, from the mucus layer composition to the adhesion molecules that regulate paracellular permeability. These alterations may represent a primary dysfunction in Crohn's disease, but they may also perpetuate chronic mucosal inflammation in ulcerative colitis. In clinical practice, several studies have documented that changes in intestinal permeability can predict IBD course. Functional tests, such as the sugar absorption tests or the novel imaging technique using confocal laser endomicroscopy, allow an in vivo assessment of gut barrier integrity. Antitumor necrosis factor-α (TNF-α) therapy reduces mucosal inflammation and restores intestinal permeability in IBD patients. Butyrate, zinc, and some probiotics also ameliorate mucosal barrier dysfunction but their use is still limited and further studies are needed before considering permeability manipulation as a therapeutic target in IBD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

![Figure 2 Confocal laser endomicroscopy images from a healthy subject (a) and an Ulcerative Colitis (UC) patient with inactive disease (b). UC patients display increased crypt diameter, intercryptic distance, and perivascular fluorescence. Courtesy of Dr. A. Buda and with permission of Journal of Crohn's and Colitis [105]; © inclusion under a Creative Commons license or any other open-access license allowing onward reuse is prohibited.](https://figures.cochat.ai/paper-figures/2164d4b5b56e4db78a431b3045efb19f/intestinal-permeability-in-inflammatory-bowel-disease-pathogenesis-clinical-figure-2.jpg)
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“This condition, known as intestinal permeability or leaky gut, has been implicated in the pathophysiology of various GI, as well as extraintestinal disorders [120,121,122], including PD [117,123,124,125,126,127,128]”
From The Interplay between Gut Microbiota and Parkinson’s Disease: Implications on Diagnosis and Treatment (2022) · cites this paper as [121]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease
Hugot, J.-P., Chamaillard, M., Zouali, H., Lesage, S., Cézard, J.-P., Belaiche, J., Almer, S., Tysk, C., O'Morain, C. A., Gassull, M., et al. (2001) · Nature · doi:10.1038/35079107 · Cited by 5,591 · cited 5×
“As a matter of fact several defects in bacterial recognition and processing have been documented in CD patients carrying particular genetic polymorphisms, chiefly of pattern-recognition receptors such as NOD2/CARD15 [68, 69] and genes involved in autophagy like ATG16L1 and IRGM [70–72].”
BackgroundInfluentialA frameshift mutation in NOD2 associated with susceptibility to Crohn's disease
Ogura, Y., Bonen, D. K., Inohara, N., Nicolae, D. L., Chen, F. F., Ramos, R., Britton, H., Moran, T., Karaliuskas, R., Duerr, R. H., et al. (2001) · Nature · doi:10.1038/35079114 · Cited by 5,030
Interactions Between the Microbiota and the Immune System
Hooper, L. V., Littman, D. R., & Macpherson, A. J. (2012) · Science · doi:10.1126/science.1223490 · Cited by 4,173 · cited 1×
“[9] “permeability” is defined as a functional feature of this barrier that on one hand allows the coexistence with bacterial symbionts necessary for our organism and on the other hand prevents luminal penetration of macromolecules and pathogens [10, 11].”
BackgroundReview article: the role of butyrate on colonic function
HAMER, H. M., JONKERS, D., VENEMA, K., VANHOUTVIN, S., TROOST, F. J., & BRUMMER, R. ‐. (2008) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2007.03562.x · Cited by 2,721
Genetics and pathogenesis of inflammatory bowel disease
Khor, B., Gardet, A., & Xavier, R. J. (2011) · Nature · doi:10.1038/nature10209 · Cited by 2,614
MICROBIAL ECOLOGY OF THE GASTROINTESTINAL TRACT
Savage, D. C. (1977) · Annual Review of Microbiology · doi:10.1146/annurev.mi.31.100177.000543 · Cited by 2,436 · cited 1×
“It is estimated that the total bacterial cell count in our body exceeds ten times the total number of human cells, with more than one thousand species hosted in the gastrointestinal tract [1, 2].”
BackgroundMachiels, K., Joossens, M., Sabino, J., De Preter, V., Arijs, I., Eeckhaut, V., Ballet, V., Claes, K., Van Immerseel, F., Verbeke, K., et al. (2014) · Gut · doi:10.1136/gutjnl-2013-304833 · Cited by 1,904 · cited 1×
“Another potential mechanism of action is the restoration of butyrate-producing bacteria: UC patients have reduced bacterial species like Faecalibacterium prausnitzii [133, 139] and supplementation with butyrate-producing species or probiotics along with preformed butyrate showed efficacy in experimental models [140, 1…”
BackgroundHampe, J., Franke, A., Rosenstiel, P., Till, A., Teuber, M., Huse, K., Albrecht, M., Mayr, G., De La Vega, F. M., Briggs, J., et al. (2007) · Nature Genetics · doi:10.1038/ng1954 · Cited by 1,897
Intestinal barrier function: molecular regulation and disease pathogenesis
Groschwitz, K. R., & Hogan, S. P. (2009) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2009.05.038 · Cited by 1,775 · cited 1×
“The mechanical cohesion of these cells and the regulation of paracellular permeability of ions and smallmolecules are ensured by three types of junctional complexes, namely, tight junctions (TJs), adherence junctions, and desmosomes [24, 26, 27].”
BackgroundIntestinal permeability – a new target for disease prevention and therapy
Bischoff, S. C., Barbara, G., Buurman, W., Ockhuizen, T., Schulzke, J.-D., Serino, M., Tilg, H., Watson, A., & Wells, J. M. (2014) · BMC Gastroenterology · doi:10.1186/s12876-014-0189-7 · Cited by 1,755 · cited 6×
“Both the probes are equally affected by gastrointestinal dilution, motility, bacterial degradation, and renal function; thus, the ratio allows for correcting possible confounding factors [9, 82].”
BackgroundInfluential
Research works printed but not linked: 1
- D'Incà R. Di Leo V. Martines D. Can permeability to sugars predict relapses in Crohn's disease? Gut 1993 34 1, supplement S50 S73
Cited by
Items 601–700 of 759
Genetic and Serological Markers in Identifying Unclassified Colitis
Fenech, V. A., Schembri, J., Ellul, P., Grech, G., & Azzopardi, N. (2016) · InTech eBooks · doi:10.5772/64587
“(TNF-alpha), alterations in the composition of the mucous layer secreted by goblet cells, and decreased defensin production by Paneth cells, especially in ileal CD [7].”
BackgroundMicrobes, Metabolites and Health
Lockett, T. J., Bird, A. R., Christophersen, C. T., Clarke, J. M., Conlon, M. A., & Topping, D. L. (2016) · Springer eBooks · doi:10.1007/978-3-319-46326-1_2 · Cited by 1
Pajić, A. (2017) · Repozitorij Farmaceutsko-biokemijskog fakulteta (Sveučilišta u Zagrebu)
Intestinal permeability as a marker of gastrointestinal health
Forsgård, R. A. (2018) · Työväentutkimus Vuosikirja
Liśkiewicz, P., Pełka-Wysiecka, J., Wroński, M., Bąba-Kubiś, A., & Samochowiec, J. (2018) · Psychiatria · Cited by 3
Intestinal targeting of small molecule MMP and TGR5 ligands for inflammatory bowel disease
Pigott, M. (2018) · Arrow@dit (Dublin Institute of Technology)
Boch, M. E. (2018) · OpenCommons - UConn (University of Connecticut) · Cited by 1
The Role of Hyaluronan in Innate Host Defense against Bacterial Infection
Kim, Y. (2017) · OhioLink ETD Center (Ohio Library and Information Network)
Hosic, S. (2019) · Digital Repository Service (Northeastern University) · doi:10.17760/d20317949
Compromised intestinal barrier underlies gut microbiota dysbiosis of intestinal diseasesPreprint
Jiang, P., Lai, S., Wu, S., Yin, X., Zhang, J., Zhao, X., Xu, S.-Q., & Chen, W. (2019) · medRxiv · doi:10.1101/19011833
“Compromised intestinal barrier (CIB) has been shown to associate with many intestinal diseases, including inflammatory bowel diseases (IBD) [17] and CRC [18, 19].”
BackgroundLean Personalized Medicine? From genetic reductionism towards holistic Personalized Medicine
Mählmann, L. (2018) · Research Publications (Maastricht University) · doi:10.26481/dis.20180710lm
The Definition and Aetiology of Long‐Term Conditions
Bill, S., & Barklam, A. D. (2020) · Wiley eBooks · doi:10.1002/9781119653134.ch1
Trotman, G. P. (2020) · University of Birmingham Institutional Research Archive (University of Birmingham)
Prospecting the insect model, Galleria mellonella, for gut-related pathobiology
Emery, H. (2020) · Cronfa (Swansea University) · doi:10.23889/suthesis.56984
Balanites aegyptiaca Extract Inhibits COX-2 and P53 Expression in DSS-induced Ulcerative Colitis
Hussein, M. A., Abdelghany, N. S., Elsayed, D. R., Mahmoud, T. M., Abdelhay, R. M., Mohamed, M. N., Abdelaal, N. A., Abdelhaleem, N. M., Nasser, S. E., Ali, A., et al. (2021) · Acta Scientifci Nutritional Health · doi:10.31080/asnh.2020.05.0870
Chikina, A. S., Nadalin, F., Maurin, M., Jouve, M. J., Thomas-Bonafos, T., Li, X. V., Lameiras, S., Baulande, S., Henri, S., MALISSEN, B., et al. (2020) · SSRN Electronic Journal · doi:10.2139/ssrn.3582693
Sharma, P., Suryakumar, G., Tanwar, H., Misra, K., & Ganju, L. (2020) · International Journal of Environment and Health Sciences · doi:10.47062/1190.0203.05
Shadnoush, M., Nazari, M., Hajianfar, H., & Faghfoori, Z. (2021) · کومش · doi:10.52547/koomesh.23.2.211
Dudeja, P. K., & Priyamvada, S. (2018) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.732715858.793545540
(2016) · Elsevier eBooks · doi:10.1016/b978-3-437-21833-0.16001-2
Daumas, C. B., & Oliveira, R. B. D. A. (2022) · doi:10.22533/at.ed.47022290612 · Cited by 1
SCOPING REVIEW – BABY-LED WEANING (BLW): UMA ALTERNATIVA AO MÉTODO TRADICIONAL
Chora, M. A. F. C., & Simões, J. F. D. C. (2022) · doi:10.22533/at.ed.47022290613 · Cited by 1
FITOQUÍMICOS DO BAGAÇO DA UVA: INGREDIENTE FUNCIONAL EM PRODUTOS CÁRNEOS
Vinha, A. F., Sousa, G. D. M. E., Silva, C., Brenha, J., & Sampaio, R. (2022) · doi:10.22533/at.ed.4702229066 · Cited by 5
Fontolan, M. V., Fontana, R. D. F., & Lima, R. D. S. (2022) · doi:10.22533/at.ed.47022290615
RELAÇÃO DOS PROBIÓTICOS E DISBIOSE INTESTINAL
Pinho, M. I. G., Farias, A. B. B., Viana, J. D. D. R., Pereira, M. T. L., Lira, C. A. C., Silva, S. D. S., Luz, P. S., Ferreira, V. A., Ferreira, A. T., Monteiro, A. I. D. S., et al. (2022) · doi:10.22533/at.ed.4702229069
PERSPECTIVAS E IMPACTOS DO CONSUMO DE ALIMENTOS ISENTOS DE GLÚTEN
Gatto, N., Júnior, A. W., Tonial, I. B., & Lucchetta, L. (2022) · doi:10.22533/at.ed.4702229065
ESTUDO DA AÇÃO DAS ENZIMAS BROMELINA E PAPAÍNA NA MACIEZ DE CARNES BOVINA E SUÍNA
Brasil, H. A., Campos, L. B., Trindade, L. W., & Quemel, G. K. C. (2022) · doi:10.22533/at.ed.4702229062
ASPECTOS NUTRICIONAIS NOS DISTÚRBIOS DA COAGULAÇÃO E AGREGAÇÃO PLAQUETÁRIA
Vieira, E. E. S., de Carvalho, V. B. L., Brito, A. K. D. S., de Almondes, R. S., Gomes, V. L. D., Souza, R. P., & de Sousa, R. W. R. (2022) · doi:10.22533/at.ed.47022290610
KEFIR: PRODUÇÃO DE UM SORVETE FUNCIONAL FERMENTADO COM AÇAÍ
Menna, A. D. A. T., Fröhlich, C. S., da Silva, D. F., Roesler, F. T., dos Santos, K. R., & Rossi, R. C. (2022) · doi:10.22533/at.ed.4702229063
RHEOLOGY OF BAKERY PRODUCTS - FLOURS, DOUGHS AND BAKED GOODS, INCLUDING TEXTURE: A SHORT REVIEW
dos Santos, D. C. A., & Lannes, S. C. D. S. (2022) · doi:10.22533/at.ed.4702229067 · Cited by 1
de Oliveira, V. V. (2022) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.10.2022.tde-07072022-113159
Muzzi, C. (2022) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-9400
Vermandere, K., Bostick, R. M., Tran, H. Q., Gewirtz, A. T., Barry, E. L., Rutherford, R. E., Seabrook, M. E., & Fedirko, V. (2023) · doi:10.1158/1940-6207.c.6547543.v1
Gıda Emülgatörleri İnflamatuvar Bağırsak Hastalıkları İçin Risk Olabilir mi?
Bekar, C., & Ayaz, A. (2023) · Journal of Nutrition and Dietetics · doi:10.33076/2023.bdd.1694
Celiac Disease and the Potential of Stems Cells as Treatment
Gallicchio, V. S. (2023) · doi:10.46889/jrmbr.2023.4202
Mucus Perspective to Conduct the Molecular Concertation in Inflammatory Bowel DiseasesPreprint
Sardelli, L., Boeri, L., Guagliano, G., Merli, M., Vangosa, F. B., & Petrini, P. (2023) · Preprints.org · doi:10.20944/preprints202305.2116.v1
The role of sex steroid hormones in Crohn\'s disease
Silva, M. D. (2023) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.17.2023.tde-30062023-093802
Fertility in Inflammatory Bowel Disease
Druvefors, E. (2023) · Linköping University medical dissertations · doi:10.3384/9789180752862
Snyder, J. R. (2023) · Digital Repository Service (Northeastern University) · doi:10.17760/d20581982
Normal and disease-associated levels of specific IgG against food antigens
Patrakeeva, V. P., Анатольевич, Ш. В., & Alesich, R. S. (2023) · Medicine of Extreme Situations · doi:10.47183/mes.2023.049
Characterization of the rat Atg16l1 gene and its role in autophagy and disease
Chesney, K. L. (2020) · MOspace Institutional Repository (University of Missouri) · doi:10.32469/10355/88869
Boumessid, K. (2023) · theses.fr (ABES) · doi:10.70675/06f173d9zbd65z45f5zac91z02ce8e6157e3
Intestinal phage-bacteria interactions across scales
Lamy-Besnier, Q. (2021) · theses.fr (ABES) · doi:10.70675/0e6f620fz20adz4df9z947fzccfc8abb9d94
Tapias, N. S. (2018) · theses.fr (ABES) · doi:10.70675/905f333fz81cdz403fza153z71355d6254ef · Cited by 2
Avancées dans le diagnostic biologique des maladies inflammatoires chroniques de l’intestin
Carlé, C., Bost, C., Cosquer, G. L., & Fortenfant, F. (2024) · Revue Francophone des Laboratoires · doi:10.1016/s1773-035x(24)00176-x
Molecular Self-Assembling Antioxidants (RNP) for Cancer Therapy
Nagasaki, Y. (2024) · Nanomedicine and nanotoxicology · doi:10.1007/978-981-97-5288-1_2
Research Progress on the Mechanism of Endoplasmic Reticulum Stress in Ulcerative Colitis
陈, 小. (2024) · Hans Journal of Biomedicine · doi:10.12677/hjbm.2024.144069
Application of Polymers as Drug Nanocarriers in the Oral Treatment of Ulcerative Colitis
Liu, X., Huang, L., Wu, E., Wei, Z., Wang, J., & Chen, Z. (2024) · ChemistrySelect · doi:10.1002/slct.202403315
Alabd, R. E., Oufi, H. G., & Alkhalidi, N. M. F. (2024) · Pakistan Journal of Nutrition · doi:10.3923/pjn.2024.73.80
Lee, M.-R., Kim, B., Kim, H., & Lee, Y. (2024) · Korean Journal of Medicinal Crop Science · doi:10.7783/kjmcs.2024.32.6.393
Mechanistic Role of Coumarins Useful in Mitigating Inflammatory Bowel Disease
Shah, B., Sharma, A., Prajapati, V., Shah, N., Maheshwari, M., & Solanki, N. D. (2025) · Revista Brasileira de Farmacognosia · doi:10.1007/s43450-025-00647-7
“…the exact cause of inflammatory bowel disease remains unclear, several contributing factors have been identified, including genetic predisposition, a dysregulated immune response, impaired intestinal barrier function, and environmental influences (Michielan and Dinca 2015; Seye-dian et al. 2019).”
Gut Barrier Permeability, Microbiota, and Brain Health: Oxford Handbook
Madison, A. A., Duff, A. F., & Bailey, M. T. (2025) · Oxford University Press eBooks · doi:10.1093/oxfordhb/9780190931544.013.17
Sleiman, J., Gaballa, A., Aslam, T., Rizvi, T. A., & Sayegh, S. E. E. (2025) · PubMed Central · doi:10.7759/cureus.88113
“This increase in mortality could be explained by the fact that both patients with IBD and ESRD have increased gastrointestinal permeability, which can lead to translocation of gut microbiota, including C diff toxins, which further increases the risk of CDI and its complications [29,30].”
Marín‐Jiménez, I., Sierra‐Ausín, M., Letosa-Abián, T., Aparicio, J., Montoto-Otero, C., & Sánchez‐Ramón, S. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1699203 · Cited by 1
Regulation of colonic mucus and epithelial cell barrier function by cathelicidin
Blyth, G. A. D. (2022) · doi:10.11575/prism/39798 · Cited by 1
Kim, J. E., Song, H. J., Choi, Y. J., Jin, Y. J., Roh, Y. J., Seol, A., Park, S. H., Park, J. M., Kang, H. G., & Hwang, D. Y. (2024) · Figshare · doi:10.6084/m9.figshare.26558831
Murugan, S. K., Bethapudi, B., Raghunandhakumar, S., Purusothaman, D., Nithyanantham, M., Mundkinajeddu, D., & Talkad, M. S. (2022) · Figshare · doi:10.6084/m9.figshare.19136111
Łoniewski, I., Szulińska, M., Kaczmarczyk, M., Podsiadło, K., Styburski, D., Skonieczna‐Żydecka, K., & Bogdański, P. (2024) · Figshare · doi:10.6084/m9.figshare.26553089
Tu, K.-C., Yu, R.-Y., Lin, Y.-H., Chien, C.-C., & Lu, C.-L. (2023) · Figshare · doi:10.6084/m9.figshare.24123939
Judkins, T. C., Solch-Ottaiano, R. J., Ceretto‐Clark, B., Nieves, C., Colee, J., Wang, Y., Tompkins, T. A., Calero, S. E. C., & Langkamp‐Henken, B. (2024) · Figshare · doi:10.6084/m9.figshare.26658355
Bachmann, J. (2023) · Elektronische Hochschulschriften der LMU München (Ludwig-Maximilians-Universität München) · doi:10.5282/edoc.32576
Holmemo, C. W. (2020) · NVA (Nasjonalt vitenarkiv)
Modelos de membrana celular para aplicaciones biomédicas.
Adwan Al Chihabi, L., Cea Mingueza, P., & Solans, S. M. (2024) · Zaguan (University of Zaragoza Repository)
Rheumatoide Arthritis im Mausmodell - immunologische und strukturelle Veränderungen im Darm
Schulz, O. (2021) · OPUS Repository (Kooperativer Bibliotheksverbund Berlin-Brandenburg)
Huang, C.-L. (2022) · The Atrium (University of Guelph) · Cited by 2
Renaud, V. (2021) · Corpus Université Laval (Université Laval) · Cited by 1
Influence de la race sur la composition du microbiote fécal du chien
Lomet, M. (2024) · HAL
Türk, E. (2023) · eArsiv - Adu (Adnan Menderes University) · Cited by 1
Quantification of secreted cytokines from an intestinal bowel disease in vitro model.
Romero Uruñuela, T. (2020) · Rovira & Virgili repository
Brdarić, E. (2023) · IMAGINE - Repository of the Institute of molecular genetics and genetic engineering (University of Belgrade)
Calcitonin gene related peptide involvement in gut health and models of Parkinson's disease
Templeton, H., Tobet, S. A., Myers, B., Smith, B. N., Moreno, J. A., & Tjalkens, R. (2025) · doi:10.25675/3.04215
В.И., С., И.В., М., О.Н., Т., С.А., А., Николаевич, А. Д., Д.С., Б., Т.Д., В., Н.М., В., В.Б., Г., Владимировна, Г. И., et al. (n.d.) · CyberLeninK (CyberLeninka) · Cited by 2
Rahimi, K., Kooti, A., Kafaie, N., Chaboksavarian, A., & Alimohammadi, M. J. (2025) · Current Research in Physiology · doi:10.1016/j.crphys.2025.100177
“These microbial components can activate TLR4-dependent signaling (Maes and Leunis, 2008; Michielan and D ’ Inc ` a, 2015).”
Evaluatie van de dikke darmomgeving en de implicaties voor het gedrag van geneesmiddelen
Steigert, S. (2025) · Lirias
Microbiota effects in a Pink1-/- mouse model of infection-induced Parkinson’s disease
Brouillard-Galipeau, M. (2024) · eScholarship@McGill (McGill) · doi:10.82308/44945
CROHN’S DISEASE: CURRENT INSIGHTS INTO PATHOGENESIS, DIAGNOSIS AND TREATMENT
Radecka, W., Grygorowicz, A., Baran, K., Ględa, M., Szyszka, M., Kozak, W., Szreiber, A., Grela, K., Nowacka, K., Jabłoński, K., et al. (2025) · International Journal of Innovative Technologies in Social Science · doi:10.31435/ijitss.4(48).2025.4666
Li, X., Yao, Y., Si, T., Wang, L., Hu, Z., Xiong, J., Bao, X., Jun, J., Bao, S., Ji, X., et al. (2026) · Toxics · doi:10.3390/toxics14010099
“This structural and functional impairment of the tight junction complex mechanistically explains the dysregulated osmotic balance observed in our model [53,54].”
Persistent Abdominal Pain in Patients with Inactive Inflammatory Bowel Disease: A Clinical Conundrum
Dell’Era, A., Antonelli, E., Fousekis, F. S., Katsanos, K. H., Maconi, G., & Bassotti, G. (2026) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izaf327
Zhao, H., Sun, Y., Li, L., Zhang, Z., Xu, X., Cui, D., & Wu, Y. (2026) · Immunologic Research · doi:10.1007/s12026-026-09745-7
“Increased intestinal permeability is central to IBD pathogenesis, as defects in the mucosal barrier enhance exposure to intestinal lumen contents, triggering immune responses that promote inflammation [ 140].”
The impact of caffeine in inflammatory bowel disease: a review of the literature
Mohamed, M. A., Chokr, D., Sundaram, H. S., Hafeez, S., Areebah, Z., Santhalingam, S., & Bishop, F. (2026) · Exploration of Digestive Diseases · doi:10.37349/edd.2026.1005112
Ito, A., Murasugi, S., Koroku, M., Yonezawa, M., Omori, T., Nakamura, S., Tokushige, K., & Nakai, Y. (2026) · BMC Gastroenterology · doi:10.1186/s12876-026-04670-3
“It is thought that the inflammation seen in UC is partly due to an excessive immune response [16].”
InfluentialRao, S., Jiang, J.-W., Zhi, S., Que, J.-H., Han, X., Tsui, S. K., & Liu, G.-M. (2026) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-026-09134-w
Wang, S., Lin, X., Liao, F., Liang, Y., Wang, C., & Gan, L. M. (2026) · Cannabis and Cannabinoid Research · doi:10.1177/25785125261428842
“65 In vivo studies by Fichna et al. 43 revealed that a synthetic cannabinoid attenuates neutrophil migration by suppressing chemotactic responsiveness.”
Kusch, J., Argyropoulos, T., Goumas, K., Tribonias, G., Reppas, C. I., & Vertzoni, M. (2026) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2026.107513
Étude de voies de signalisation en rapport avec la maladie de Crohn
Mahfouz, B. (2016) · theses.fr (ABES) · doi:10.70675/861f18d3zf785z4d38zac05z58c5c6c71b08
Nicolas, S. (2016) · theses.fr (ABES) · doi:10.70675/9bfdcec7z8f9az4d52z9c72z5f2dd4c6ad5e · Cited by 2
Metadata
- Authors
- Michielan, A., & D’Incà, R.
- Affiliations
- University of Padua (IT)
- Corresponding author
- Michielan, Andrea
- ORCID
- Michielan, Andrea
- Venue
- Mediators of Inflammation
- Publisher
- Wiley
- Published
- 2015-01
- Volume
- 2015
- Issue
- 1
- Pages
- 628157-628157
- ISSN
- 0962-9351 (ISSN-L)
- 1466-1861
- PMC
- PMC4637104
- OpenAlex
- W2176502392
- Cited by
- 709
- References
- 146
- Citations by year
- 2026: 61 · 2025: 54 · 2024: 86 · 2023: 91 · 2022: 99 · 2021: 82 · 2020: 81 · 2019: 58 · 2018: 38 · 2017: 37 · 2016: 21
- FWCI
- 4.05
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- Mediators of Inflammation (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- University of Oxford
- Topics
- Health Sciences › Medicine › Gastroenterology › Inflammatory Bowel Disease
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Keywords
- intestinal permeability, leaky gut, inflammatory bowel disease, Crohn's disease, ulcerative colitis, mucosal barrier dysfunction, gut microbiota, mucus layer, paracellular permeability, adhesion molecules, confocal laser endomicroscopy, butyrate, zinc, probiotics, intestinal inflammation
- MeSH terms
- Humans, Intestinal Mucosa, Permeability, Tumor Necrosis Factor-alpha, Zinc, Inflammatory Bowel Diseases, Probiotics
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.